PharmaCielo Ltd. announced that it has made an initial shipment of CBD Isolate to a Canadian life sciences company that specializes in developing and commercializing proprietary drug- delivery technologies. The Customer intends to use PharmaCielo's Active Pharmaceutical Ingredients (APIs) for expanded research and development of their innovative, proprietary sublingual product platform.